# OnCo record hansoh-pharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/hansoh-pharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "hansoh-pharma" ;
  schema:name "Hansoh Pharmaceutical"@en ;
  schema:alternateName "Hansoh"@en, "Hansoh Pharma"@en, "Hansoh Pharmaceutical Group"@en, "翰森制药"@en, "hansoh"@en ;
  schema:description "Hansoh is a Chinese pharmaceutical group whose EGFR inhibitor aumolertinib (Ameile in China, Aumseqa in the EU) became the first China-originated lung cancer pill authorised by the European Commission in 2026."@en ;
  schema:url <https://onco.cc/companies/hansoh-pharma/>, <https://www.hspharm.com> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Hansoh_Pharmaceutical> ;
  owl:sameAs <http://www.wikidata.org/entity/Q88925945> ;
  schema:citation <https://www.hspharm.com/> ;
  onco:tag "china" ;
  schema:addressCountry "CN" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/adcs/> ;
  onco:drugs <https://onco.cc/drugs/aumolertinib/>, <https://onco.cc/drugs/hs-20093/>, <https://onco.cc/drugs/hs-20089/>, <https://onco.cc/drugs/hs-20117/>, <https://onco.cc/drugs/flumatinib/> ;
  onco:companies <https://onco.cc/companies/gsk/>, <https://onco.cc/companies/merck/> ;
  onco:trials <https://onco.cc/trials/aeneas/>, <https://onco.cc/trials/nct05435248/>, <https://onco.cc/trials/nct07468851/>, <https://onco.cc/trials/nct05367778/>, <https://onco.cc/trials/nct06147570/>, <https://onco.cc/trials/nct07283367/>, <https://onco.cc/trials/nct04951635/>, <https://onco.cc/trials/nct04687241/>, <https://onco.cc/trials/nct05830123/>, <https://onco.cc/trials/nct06007729/>, <https://onco.cc/trials/nct04923906/>, <https://onco.cc/trials/nct06014190/>, <https://onco.cc/trials/nct06112704/> .